Skip to main content

Month: June 2020

Whitestone REIT Declares Third Quarter 2020 Dividends and Provides a Rental Collections Update

HOUSTON, June 16, 2020 (GLOBE NEWSWIRE) — Whitestone REIT’s (NYSE:WSR) (“Whitestone” or the “Company”) Board of Trustees has declared a monthly cash dividend of  $0.035 per share on the Company’s common shares and operating partnership units. The dividend amount of $0.035 per share represents a quarterly amount of $0.105, and an annualized amount of $0.42 per share. The third quarter dividend distribution for 2020 will be as detailed below:Jim Mastandrea, Chairman and Chief Executive Officer, commented, “We are pleased to announce Whitestone’s 119th, 120th, and 121st consecutive monthly dividend distributions. In an environment where many public companies are having difficulty collecting rent during the pandemic and are suspending dividends, Whitestone continues to lead the public shopping center REITs with 89% in rental collections...

Continue reading

CloudMD Secures Footprint in Ontario with Binding Term Sheet to Acquire Majority Interest in Medical Clinic

VANCOUVER, British Columbia, June 16, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company revolutionizing the delivery of healthcare to patients, is excited to announce that it has entered into a binding term sheet (the “Agreement”) to acquire a majority interest (51%) in West Mississauga Medical Ltd. (“West Mississauga Medical”), a comprehensive family medicine and specialist medical clinic with 8 family doctors and 4 specialists serving over 100,000 patients.West Mississauga Medical is a well-established medical clinic located on the border of Brampton, Mississauga and Milton in a high growth area.  The clinic has served the community for over 16 years and remained open throughout the COVID-19 pandemic seeing patients via telemedicine...

Continue reading

Kalytera Provides Update Regarding Acquisition of Salzman Group

SAN FRANCISCO, June 16, 2020 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTC: KALTF) (the “Company” or “Kalytera“) announced today that it is working with Salzman Group toward completing definitive agreements for Kalytera’s acquisition of Salzman Group (the “Acquisition”). On May 19, 2020, Kalytera announced that it had signed a binding Letter of Intent dated May 12, 2020 to acquire Salzman Group, Inc., a privately held company located in West Tisbury, MA (“Salzman Group”).Salzman Group is the owner of R-107, a proprietary drug with issued and pending composition of matter and method of use patents in approximately 40 countries, including the U.S., Australia, Brazil, China, Europe, India, Japan, Russia and South Korea. Salzman Group is developing R-107 for treatment of COVID-19 associated...

Continue reading

G4S plc: Updated Financial Calendar 2020

16 June 2020G4S PLC UPDATED FINANCIAL CALENDAR FOR 2020G4S plc, the world’s leading international security solutions provider, announces its updated financial calendar for 2020:                                                                                                           Notes to Editors:G4S is the world’s leading global, integrated security company, specialising in the provision of security services and solutions to customers. Our mission is to create material, sustainable value for our customers and shareholders by being the supply partner of choice in all our markets.G4S is quoted on the London Stock Exchange and has a secondary stock exchange listing in Copenhagen. After taking account of the businesses being sold in the year, G4S is active in around 85 countries and has around 533,000 employees. For more information on...

Continue reading

Annovis Bio Announces Positive Results from NIH Funded Chronic Toxicology Study

BERWYN, Pa., June 16, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced it successfully completed the rat cohort of a chronic toxicology study of its lead therapeutic compound ANVS401, reporting no negative side effects.The six-month rat study was part of a series of animal toxicology studies, funded by a $1.7 million grant from the National Institutes of Health, that began in the fourth quarter of 2019. The safety seen in the rats corroborates the positive results from the Company’s prior one-month safety studies in mice, rats, dogs, and humans. A nine-month dog safety study remains ongoing under the NIH funded program, with results expected in the third quarter...

Continue reading

Heimavellir hf.: Viðskipti fruminnherja og fjárhagslega tengds aðila vegna yfirtökutilboðs Fredensborg ICE ehf.

Sjá meðfylgjandi tilkynningar vegna viðskipta neðangreindra aðila:Fruminnherjar:Árni Már Markússon     – Forstöðumaður fasteignaBjarni Davíð Hjaltason –  Starfsmaður á skrifstofuErlendur Magnússon    –  Fyrrverandi formaður stjórnarFjárhagslega tengdur aðiliMakalu ehf.               –  Tengt Arnari Gauta ReynissyniViðhengiVidskipti-fruminnherja-7.5.2020 – Erlendur MagnússonVidskipti-fjarhagslega-tengds-adila-7.5.2020 – Makalu ehf.Vidskipti-fruminnherja-7.5.2020 – Árni Már MarkússonVidskipti-fruminnherja-7.5.2020 – Bjarni Davíð Hjaltason

Continue reading

Työllisyysrahasto valitsi Innofactorin IT-asiantuntijapalveluiden ensisijaiseksi puitesopimustoimittajaksi

Innofactor Oyj:n sisäpiiritieto 16.6.2020 klo 13.37Työllisyysrahasto on valinnut Innofactorin julkisen hankinnan kilpailutuksessa tietojärjestelmien ylläpidon ja kehityksen IT-asiantuntijapalveluiden ensisijaiseksi puitesopimustoimittajaksi.  Hankinnan kohteena on tietojärjestelmien ylläpidon ja kehityksen IT-asiantuntijatyö ja ohjelmistot. Asiantuntijatyötä voidaan käyttää tarpeen mukaan ylläpitoon, kehittämiseen ja tukitehtäviin. Työstä voidaan sopia yksittäisinä tehtävinä, projekteina tai jatkuvina palveluina. Toimitukset voivat sisältää ohjelmistoja tai ohjelmistokomponentteja.Puitesopimus tehdään toistaiseksi voimassa olevana, kuitenkin enintään neljäksi vuodeksi. Ensisijaisuusperiaatteen mukaisesti Innofactorin kanssa solmitaan puitesopimuksen lisäksi ensivaiheessa sovellusylläpito- ja kehitystiimin toimitussopimus. Innofactorin...

Continue reading

Employment Fund selects Innofactor as the primary framework agreement supplier of IT specialist services

Innofactor Plc Inside Information, on June 16, 2020, at 13:37 Finnish timeThe Employment Fund has selected Innofactor in a public procurement competition as its primary framework agreement supplier of maintenance and development of information systems. The procurement comprises maintenance and development IT specialist services and software. The specialist services can be utilized for maintenance, development and support according to needs. Work can be agreed as individual tasks, projects or continuous services. The deliveries may include software and software components.The framework agreement is valid until further notice with a maximum duration of four years. According to the priority principle, Innofactor is also granted a contract regarding the delivery of an application maintenance and development team in addition to the framework...

Continue reading

Affimed to Report First Quarter 2020 Financial Results & Corporate Update June 23, 2020; Company to Participate in Virtual BMO Prescriptions for Success Healthcare Conference

Heidelberg, Germany, June 16, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release first quarter 2020 results on Tuesday, June 23, 2020 and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments.The conference call will be available via phone and webcast. To access the first quarter results call, please dial +1-646-741-3167 for U.S. callers, or +44 (0) 2071 928338 for international callers, and reference conference ID 8594214 approximately 15 minutes prior to the call.To access the live audio webcast of the conference call please visit the “Investors” section of company’s website at https://www.affimed.com/investors/webcasts_cp/. A replay of the call will be...

Continue reading

AGM Statement and update

For immediate release            16 June 2020Serabi Gold plc(“Serabi” or the “Company”)AGM Statement and updateSerabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focused gold mining and development company, advises that at 2.00 pm today (UK time), it will be holding its Annual General Meeting (the “Meeting”)As advised in the Notice of Meeting issued on 15 May 2020, to conform with the UK government’s mandatory measures to reduce the transmission of COVID-19, including certain travel arrangements and public gatherings, shareholders are reminded not to attend in person and it will not be possible to gain access to the Meeting.  Details of the results of the votes cast at the Meeting will be issued later today.Typically, the Company’s Chief Executive, Mike Hodgson, would make a statement to the Meeting outlining the achievements of the Company...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.